The Amyloid Fibril-Forming β-Sheet Regions of Amyloid β and α-Synuclein Preferentially Interact with the Molecular Chaperone 14-3-3ζ

被引:10
|
作者
Williams, Danielle M. [1 ]
Thorn, David C. [2 ]
Dobson, Christopher M. [3 ]
Meehan, Sarah [3 ]
Jackson, Sophie E. [3 ]
Woodcock, Joanna M. [4 ]
Carver, John A. [2 ]
机构
[1] Univ Adelaide, Sch Phys Sci, Dept Chem, Adelaide, SA 5001, Australia
[2] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia
[3] Univ Cambridge, Yusuf Hamied Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England
[4] Ctr Canc Biol, Adelaide, SA 5000, Australia
来源
MOLECULES | 2021年 / 26卷 / 20期
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
14-3-3; proteins; molecular chaperone; amyloid beta; alpha-synuclein; NMR spectroscopy; amyloid fibril; B-CRYSTALLIN; AGGREGATION; PROTEIN; BINDING; STATE; SPECTROSCOPY; PROTEOSTASIS; LACTALBUMIN; DYNAMICS; REVEALS;
D O I
10.3390/molecules26206120
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
14-3-3 proteins are abundant, intramolecular proteins that play a pivotal role in cellular signal transduction by interacting with phosphorylated ligands. In addition, they are molecular chaperones that prevent protein unfolding and aggregation under cellular stress conditions in a similar manner to the unrelated small heat-shock proteins. In vivo, amyloid beta (A beta) and alpha-synuclein (alpha-syn) form amyloid fibrils in Alzheimer's and Parkinson's diseases, respectively, a process that is intimately linked to the diseases' progression. The 14-3-3 zeta isoform potently inhibited in vitro fibril formation of the 40-amino acid form of A beta (A beta(40)) but had little effect on alpha-syn aggregation. Solution-phase NMR spectroscopy of N-15-labeled A beta(40) and A53T alpha-syn determined that unlabeled 14-3-3 zeta interacted preferentially with hydrophobic regions of A beta(40) (L11-H21 and G29-V40) and alpha-syn (V3-K10 and V40-K60). In both proteins, these regions adopt beta-strands within the core of the amyloid fibrils prepared in vitro as well as those isolated from the inclusions of diseased individuals. The interaction with 14-3-3 zeta is transient and occurs at the early stages of the fibrillar aggregation pathway to maintain the native, monomeric, and unfolded structure of A beta(40) and alpha-syn. The N-terminal regions of alpha-syn interacting with 14-3-3 zeta correspond with those that interact with other molecular chaperones as monitored by in-cell NMR spectroscopy.
引用
收藏
页数:14
相关论文
共 30 条
  • [21] Role of salt bridges in the dimer interface of 14-3-3ζ in dimer dynamics, N-terminal α-helical order, and molecular chaperone activity
    Woodcock, Joanna M.
    Goodwin, Katy L.
    Sandow, Jarrod J.
    Coolen, Carl
    Perugini, Matthew A.
    Webb, Andrew I.
    Pitson, Stuart M.
    Lopez, Angel F.
    Carver, John A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (01) : 89 - 99
  • [22] α-Synuclein amyloid fibril directly binds to LC3B and suppresses SQSTM1/p62-mediated selective autophagy
    Xu, Qianhui
    Wang, Huilan
    Yang, Ruonan
    Tao, Youqi
    Wang, Ziying
    Zhang, Shengnan
    Sun, Bo
    Li, Dan
    Lu, Boxun
    Liu, Cong
    CELL RESEARCH, 2025, 35 (01) : 72 - 75
  • [23] Multiple β-sheet molecular dynamics of amyloid formation from two ABl-SH3 domain peptides
    Lapidus, Dmitrijs
    Duka, Vita
    Stonkus, Vladislavs
    Czaplewski, Cezary
    Liwo, Adam
    Ventura, Salvador
    Liepina, Inta
    BIOPOLYMERS, 2012, 98 (06) : 557 - 566
  • [24] OXIDATIVE DAMAGE OF 14-3-3 ZETA AND GAMMA ISOFORMS IN ALZHEIMER'S DISEASE AND CEREBRAL AMYLOID ANGIOPATHY (Retraction of vol 146, pg 1640, 2007)
    Santpere, G.
    Puig, B.
    Ferrer, I.
    NEUROSCIENCE, 2009, 161 (02) : 663 - 663
  • [25] Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation
    Poska, Helen
    Leppert, Axel
    Tigro, Helene
    Zhong, Xueying
    Kaldmae, Margit
    Nilsson, Harriet E.
    Hebert, Hans
    Chen, Gefei
    Johansson, Jan
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation
    Helen Poska
    Axel Leppert
    Helene Tigro
    Xueying Zhong
    Margit Kaldmäe
    Harriet E Nilsson
    Hans Hebert
    Gefei Chen
    Jan Johansson
    Scientific Reports, 10
  • [27] Intravenous treatment with a molecular chaperone designed against f3-amyloid toxicity improves Alzheimer?s disease pathology in mouse models
    Manchanda, Shaffi
    Galan-Acosta, Lorena
    Abelein, Axel
    Tambaro, Simone
    Chen, Gefei
    Nilsson, Per
    Johansson, Jan
    MOLECULAR THERAPY, 2023, 31 (02) : 487 - 502
  • [28] Molecular dynamics of amyloid formation of two Abl-SH3 domain peptides: parallel and antiparallel beta-sheet structures
    Lapidus, D.
    Duka, V.
    Stonkus, V.
    Ventura, S.
    Czaplewski, C.
    Liwo, A.
    Liepina, I.
    JOURNAL OF PEPTIDE SCIENCE, 2012, 18 : S77 - S77
  • [29] Diagnosis contribution of CSF biomarkers (tau, phosphotau, beta-amyloid, 14-3-3, S100B) in 120 patients with cognitive disorders: data from a prospective longitudinal cohort
    Viallet, F.
    Thoannes, H.
    Bonnefoi, B.
    Gayraud, D.
    Renie, L.
    Sappa, E.
    Frayssinet, F.
    Farinet, C.
    Fedorca, A.
    Gharibyian, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 59 - 59
  • [30] RETRACTED: Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy (Retracted article. See vol. 161, pg. 663, 2009)
    Santpere, G.
    Puig, B.
    Ferrer, I.
    NEUROSCIENCE, 2007, 146 (04) : 1640 - 1651